Medicines during pregnancy and breastfeeding

Human medicines European public assessment report (EPAR): Azarga, brinzolamide,timolol, Date of authorisation: 25/11/2008, Revision: 19, Status: Authorised

Drug Shortages Global Regulatory Working Group: Group statement published on behalf of the Working Group by EMA

Human medicines European public assessment report (EPAR): Dasatinib Accord Healthcare, dasatinib, Date of authorisation: 26/07/2024, Revision: 3, Status: Authorised

Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 26-29 January 2026

Human medicines European public assessment report (EPAR): Lyxumia, lixisenatide, Date of authorisation: 31/01/2013, Revision: 21, Status: Withdrawn

Committee for Advanced Therapies (CAT): 3-5 December 2025, European Medicines Agency, Amsterdam, the Netherlands, from 3 December 2025 to 5 December 2025

Applications for new human medicines under evaluation: February 2026

List of medicines currently in PRIME scheme

Human medicines European public assessment report (EPAR): DuoTrav, travoprost,timolol, Date of authorisation: 23/04/2006, Revision: 20, Status: Authorised